Loading clinical trials...
Loading clinical trials...
The primary purpose of this study is to determine the best dose of tezacitabine when combined with oxaliplatin in patients with metastatic colorectal cancer. This study will also evaluate tumor respon...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Chiron Corporation
NCT07541924 · Colorectal Cancer Screening, Colonic Polyps/Colonoscopy/Colorectal Neoplasms, and more
NCT06662786 · Colorectal Neoplasms
NCT06663319 · Colorectal Neoplasms, Gastrointestinal Neoplasms
NCT05239741 · Colorectal Neoplasms
NCT06342401 · Colorectal Cancer, Colorectal Neoplasms, and more
ACRC/Arizona Clinical Research Center
Tucson, Arizona
USC/Norris Comprehensive Cancer Center
Los Angeles, California
Comprehensive Cancer Centers of the Desert
Palm Springs, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions